nodes	percent_of_prediction	percent_of_DWPC	metapath
Omeprazole—CYP1A1—chronic obstructive pulmonary disease	0.214	0.509	CbGaD
Omeprazole—CYP1A2—chronic obstructive pulmonary disease	0.207	0.491	CbGaD
Omeprazole—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.0293	0.0865	CbGbCtD
Omeprazole—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.0293	0.0865	CbGbCtD
Omeprazole—CYP2C8—Montelukast—chronic obstructive pulmonary disease	0.0264	0.0781	CbGbCtD
Omeprazole—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0243	0.0719	CbGbCtD
Omeprazole—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0243	0.0719	CbGbCtD
Omeprazole—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.023	0.0679	CbGbCtD
Omeprazole—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0223	0.0658	CbGbCtD
Omeprazole—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0223	0.0658	CbGbCtD
Omeprazole—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0198	0.0586	CbGbCtD
Omeprazole—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0187	0.0552	CbGbCtD
Omeprazole—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.0184	0.0545	CbGbCtD
Omeprazole—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0126	0.0373	CbGbCtD
Omeprazole—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.0123	0.0363	CbGbCtD
Omeprazole—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.012	0.0356	CbGbCtD
Omeprazole—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0107	0.0317	CbGbCtD
Omeprazole—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.0105	0.031	CbGbCtD
Omeprazole—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.00992	0.0293	CbGbCtD
Omeprazole—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00629	0.0186	CbGbCtD
Omeprazole—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00594	0.0176	CbGbCtD
Omeprazole—Rabeprazole—CYP1A1—chronic obstructive pulmonary disease	0.000796	0.228	CrCbGaD
Omeprazole—Pantoprazole—CYP1A2—chronic obstructive pulmonary disease	0.000767	0.22	CrCbGaD
Omeprazole—Rabeprazole—CYP1A2—chronic obstructive pulmonary disease	0.000767	0.22	CrCbGaD
Omeprazole—Lansoprazole—CYP1A1—chronic obstructive pulmonary disease	0.000593	0.17	CrCbGaD
Omeprazole—Lansoprazole—CYP1A2—chronic obstructive pulmonary disease	0.000572	0.164	CrCbGaD
Omeprazole—ATP4A—respiratory system—chronic obstructive pulmonary disease	0.000394	0.143	CbGeAlD
Omeprazole—ATP4A—connective tissue—chronic obstructive pulmonary disease	0.000347	0.126	CbGeAlD
Omeprazole—CYP2C18—bronchus—chronic obstructive pulmonary disease	0.000267	0.0968	CbGeAlD
Omeprazole—CYP11A1—connective tissue—chronic obstructive pulmonary disease	0.000227	0.0825	CbGeAlD
Omeprazole—ABCC3—respiratory system—chronic obstructive pulmonary disease	0.0002	0.0728	CbGeAlD
Omeprazole—CYP1B1—respiratory system—chronic obstructive pulmonary disease	0.000157	0.057	CbGeAlD
Omeprazole—Dry skin—Prednisolone—chronic obstructive pulmonary disease	0.000141	0.000961	CcSEcCtD
Omeprazole—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000141	0.000961	CcSEcCtD
Omeprazole—Oesophagitis—Prednisone—chronic obstructive pulmonary disease	0.000141	0.000959	CcSEcCtD
Omeprazole—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.00014	0.000952	CcSEcCtD
Omeprazole—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.00014	0.000952	CcSEcCtD
Omeprazole—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.00014	0.00095	CcSEcCtD
Omeprazole—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000139	0.000945	CcSEcCtD
Omeprazole—Infection—Formoterol—chronic obstructive pulmonary disease	0.000139	0.000945	CcSEcCtD
Omeprazole—CYP1B1—connective tissue—chronic obstructive pulmonary disease	0.000138	0.0501	CbGeAlD
Omeprazole—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000138	0.000937	CcSEcCtD
Omeprazole—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000138	0.000937	CcSEcCtD
Omeprazole—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000138	0.000937	CcSEcCtD
Omeprazole—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000138	0.000937	CcSEcCtD
Omeprazole—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000137	0.000934	CcSEcCtD
Omeprazole—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000137	0.000933	CcSEcCtD
Omeprazole—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000137	0.000933	CcSEcCtD
Omeprazole—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000137	0.000932	CcSEcCtD
Omeprazole—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000137	0.000932	CcSEcCtD
Omeprazole—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000136	0.000929	CcSEcCtD
Omeprazole—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000136	0.000929	CcSEcCtD
Omeprazole—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000136	0.000926	CcSEcCtD
Omeprazole—Infection—Montelukast—chronic obstructive pulmonary disease	0.000136	0.000926	CcSEcCtD
Omeprazole—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.000136	0.000925	CcSEcCtD
Omeprazole—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000136	0.000924	CcSEcCtD
Omeprazole—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000136	0.000924	CcSEcCtD
Omeprazole—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000135	0.000921	CcSEcCtD
Omeprazole—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000135	0.000917	CcSEcCtD
Omeprazole—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000134	0.000914	CcSEcCtD
Omeprazole—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000134	0.000913	CcSEcCtD
Omeprazole—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.000134	0.000912	CcSEcCtD
Omeprazole—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000133	0.000905	CcSEcCtD
Omeprazole—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000132	0.000898	CcSEcCtD
Omeprazole—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000131	0.000893	CcSEcCtD
Omeprazole—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000131	0.000888	CcSEcCtD
Omeprazole—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00013	0.000885	CcSEcCtD
Omeprazole—Shock—Salbutamol—chronic obstructive pulmonary disease	0.00013	0.000884	CcSEcCtD
Omeprazole—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.00013	0.000883	CcSEcCtD
Omeprazole—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000129	0.000881	CcSEcCtD
Omeprazole—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000129	0.000877	CcSEcCtD
Omeprazole—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000128	0.000873	CcSEcCtD
Omeprazole—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000128	0.000869	CcSEcCtD
Omeprazole—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000128	0.000869	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000127	0.000867	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000127	0.000867	CcSEcCtD
Omeprazole—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000126	0.000861	CcSEcCtD
Omeprazole—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000126	0.000861	CcSEcCtD
Omeprazole—CYP1B1—smooth muscle tissue—chronic obstructive pulmonary disease	0.000126	0.0459	CbGeAlD
Omeprazole—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000126	0.000856	CcSEcCtD
Omeprazole—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000126	0.000855	CcSEcCtD
Omeprazole—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	0.000125	0.000852	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000125	0.000849	CcSEcCtD
Omeprazole—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000125	0.000848	CcSEcCtD
Omeprazole—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000125	0.000848	CcSEcCtD
Omeprazole—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000124	0.000846	CcSEcCtD
Omeprazole—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000124	0.000846	CcSEcCtD
Omeprazole—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000124	0.000843	CcSEcCtD
Omeprazole—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000123	0.000838	CcSEcCtD
Omeprazole—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000123	0.000838	CcSEcCtD
Omeprazole—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000123	0.000837	CcSEcCtD
Omeprazole—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000123	0.000834	CcSEcCtD
Omeprazole—Injury—Prednisone—chronic obstructive pulmonary disease	0.000122	0.000829	CcSEcCtD
Omeprazole—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000122	0.000829	CcSEcCtD
Omeprazole—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000121	0.000827	CcSEcCtD
Omeprazole—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000121	0.000825	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000121	0.000821	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000121	0.000821	CcSEcCtD
Omeprazole—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000121	0.00082	CcSEcCtD
Omeprazole—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000121	0.00082	CcSEcCtD
Omeprazole—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000121	0.00082	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00012	0.000819	CcSEcCtD
Omeprazole—Constipation—Formoterol—chronic obstructive pulmonary disease	0.00012	0.000814	CcSEcCtD
Omeprazole—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.00012	0.000814	CcSEcCtD
Omeprazole—Pain—Arformoterol—chronic obstructive pulmonary disease	0.00012	0.000814	CcSEcCtD
Omeprazole—Pain—Formoterol—chronic obstructive pulmonary disease	0.00012	0.000814	CcSEcCtD
Omeprazole—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000119	0.000813	CcSEcCtD
Omeprazole—Increased appetite—Prednisone—chronic obstructive pulmonary disease	0.000119	0.000811	CcSEcCtD
Omeprazole—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000119	0.000807	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000118	0.000805	CcSEcCtD
Omeprazole—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000118	0.000804	CcSEcCtD
Omeprazole—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000118	0.000801	CcSEcCtD
Omeprazole—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000117	0.000799	CcSEcCtD
Omeprazole—Pain—Montelukast—chronic obstructive pulmonary disease	0.000117	0.000797	CcSEcCtD
Omeprazole—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000117	0.000795	CcSEcCtD
Omeprazole—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000116	0.000791	CcSEcCtD
Omeprazole—Purpura—Prednisone—chronic obstructive pulmonary disease	0.000116	0.00079	CcSEcCtD
Omeprazole—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000116	0.000788	CcSEcCtD
Omeprazole—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000116	0.000788	CcSEcCtD
Omeprazole—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000115	0.000785	CcSEcCtD
Omeprazole—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000115	0.000784	CcSEcCtD
Omeprazole—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000115	0.000784	CcSEcCtD
Omeprazole—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000115	0.000783	CcSEcCtD
Omeprazole—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000115	0.000781	CcSEcCtD
Omeprazole—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000115	0.00078	CcSEcCtD
Omeprazole—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000114	0.000778	CcSEcCtD
Omeprazole—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000114	0.000778	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000114	0.000776	CcSEcCtD
Omeprazole—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000114	0.000775	CcSEcCtD
Omeprazole—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000113	0.000768	CcSEcCtD
Omeprazole—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000113	0.000768	CcSEcCtD
Omeprazole—CYP1A2—respiratory system—chronic obstructive pulmonary disease	0.000112	0.0408	CbGeAlD
Omeprazole—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000112	0.000762	CcSEcCtD
Omeprazole—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.000112	0.000762	CcSEcCtD
Omeprazole—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000112	0.000762	CcSEcCtD
Omeprazole—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000111	0.000756	CcSEcCtD
Omeprazole—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000111	0.000756	CcSEcCtD
Omeprazole—CYP1A1—respiratory system—chronic obstructive pulmonary disease	0.000111	0.0403	CbGeAlD
Omeprazole—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000111	0.000752	CcSEcCtD
Omeprazole—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000111	0.000752	CcSEcCtD
Omeprazole—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000111	0.000752	CcSEcCtD
Omeprazole—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000111	0.000752	CcSEcCtD
Omeprazole—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00011	0.00075	CcSEcCtD
Omeprazole—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000109	0.000743	CcSEcCtD
Omeprazole—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000109	0.000743	CcSEcCtD
Omeprazole—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000109	0.000743	CcSEcCtD
Omeprazole—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000109	0.00074	CcSEcCtD
Omeprazole—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000109	0.00074	CcSEcCtD
Omeprazole—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000109	0.000739	CcSEcCtD
Omeprazole—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000109	0.000738	CcSEcCtD
Omeprazole—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000108	0.000737	CcSEcCtD
Omeprazole—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000108	0.000737	CcSEcCtD
Omeprazole—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.000108	0.000736	CcSEcCtD
Omeprazole—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000108	0.000735	CcSEcCtD
Omeprazole—Irritability—Prednisone—chronic obstructive pulmonary disease	0.000107	0.000727	CcSEcCtD
Omeprazole—ABCC3—lung—chronic obstructive pulmonary disease	0.000106	0.0386	CbGeAlD
Omeprazole—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000105	0.000714	CcSEcCtD
Omeprazole—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000104	0.00071	CcSEcCtD
Omeprazole—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000104	0.00071	CcSEcCtD
Omeprazole—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000103	0.000701	CcSEcCtD
Omeprazole—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000103	0.000701	CcSEcCtD
Omeprazole—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000103	0.0007	CcSEcCtD
Omeprazole—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000103	0.000699	CcSEcCtD
Omeprazole—Dry skin—Prednisone—chronic obstructive pulmonary disease	0.000103	0.000698	CcSEcCtD
Omeprazole—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	0.000102	0.000693	CcSEcCtD
Omeprazole—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000101	0.000687	CcSEcCtD
Omeprazole—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.0001	0.000683	CcSEcCtD
Omeprazole—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.0001	0.000683	CcSEcCtD
Omeprazole—Pruritus—Formoterol—chronic obstructive pulmonary disease	9.89e-05	0.000673	CcSEcCtD
Omeprazole—Pruritus—Arformoterol—chronic obstructive pulmonary disease	9.89e-05	0.000673	CcSEcCtD
Omeprazole—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	9.87e-05	0.000672	CcSEcCtD
Omeprazole—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	9.87e-05	0.000672	CcSEcCtD
Omeprazole—Asthenia—Montelukast—chronic obstructive pulmonary disease	9.83e-05	0.000669	CcSEcCtD
Omeprazole—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	9.74e-05	0.000663	CcSEcCtD
Omeprazole—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	9.73e-05	0.000662	CcSEcCtD
Omeprazole—Pruritus—Montelukast—chronic obstructive pulmonary disease	9.69e-05	0.000659	CcSEcCtD
Omeprazole—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	9.57e-05	0.000651	CcSEcCtD
Omeprazole—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	9.57e-05	0.000651	CcSEcCtD
Omeprazole—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	9.49e-05	0.000646	CcSEcCtD
Omeprazole—Asthenia—Salbutamol—chronic obstructive pulmonary disease	9.47e-05	0.000645	CcSEcCtD
Omeprazole—Sweating increased—Prednisone—chronic obstructive pulmonary disease	9.43e-05	0.000641	CcSEcCtD
Omeprazole—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	9.37e-05	0.000638	CcSEcCtD
Omeprazole—Pruritus—Salbutamol—chronic obstructive pulmonary disease	9.34e-05	0.000636	CcSEcCtD
Omeprazole—Dizziness—Arformoterol—chronic obstructive pulmonary disease	9.25e-05	0.000629	CcSEcCtD
Omeprazole—Dizziness—Formoterol—chronic obstructive pulmonary disease	9.25e-05	0.000629	CcSEcCtD
Omeprazole—CYP1A1—bronchus—chronic obstructive pulmonary disease	9.13e-05	0.0331	CbGeAlD
Omeprazole—Dizziness—Montelukast—chronic obstructive pulmonary disease	9.06e-05	0.000616	CcSEcCtD
Omeprazole—Neutropenia—Prednisone—chronic obstructive pulmonary disease	9.05e-05	0.000616	CcSEcCtD
Omeprazole—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	9.03e-05	0.000615	CcSEcCtD
Omeprazole—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	8.91e-05	0.000606	CcSEcCtD
Omeprazole—Vomiting—Arformoterol—chronic obstructive pulmonary disease	8.89e-05	0.000605	CcSEcCtD
Omeprazole—Vomiting—Formoterol—chronic obstructive pulmonary disease	8.89e-05	0.000605	CcSEcCtD
Omeprazole—Rash—Arformoterol—chronic obstructive pulmonary disease	8.82e-05	0.0006	CcSEcCtD
Omeprazole—Rash—Formoterol—chronic obstructive pulmonary disease	8.82e-05	0.0006	CcSEcCtD
Omeprazole—Dermatitis—Formoterol—chronic obstructive pulmonary disease	8.81e-05	0.000599	CcSEcCtD
Omeprazole—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	8.81e-05	0.000599	CcSEcCtD
Omeprazole—Weight increased—Prednisone—chronic obstructive pulmonary disease	8.81e-05	0.000599	CcSEcCtD
Omeprazole—Headache—Arformoterol—chronic obstructive pulmonary disease	8.76e-05	0.000596	CcSEcCtD
Omeprazole—Headache—Formoterol—chronic obstructive pulmonary disease	8.76e-05	0.000596	CcSEcCtD
Omeprazole—Weight decreased—Prednisone—chronic obstructive pulmonary disease	8.75e-05	0.000596	CcSEcCtD
Omeprazole—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	8.74e-05	0.000595	CcSEcCtD
Omeprazole—Dizziness—Salbutamol—chronic obstructive pulmonary disease	8.73e-05	0.000594	CcSEcCtD
Omeprazole—Vomiting—Montelukast—chronic obstructive pulmonary disease	8.71e-05	0.000593	CcSEcCtD
Omeprazole—Rash—Montelukast—chronic obstructive pulmonary disease	8.64e-05	0.000588	CcSEcCtD
Omeprazole—Dermatitis—Montelukast—chronic obstructive pulmonary disease	8.63e-05	0.000587	CcSEcCtD
Omeprazole—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	8.61e-05	0.000586	CcSEcCtD
Omeprazole—Depression—Prednisone—chronic obstructive pulmonary disease	8.6e-05	0.000585	CcSEcCtD
Omeprazole—Headache—Montelukast—chronic obstructive pulmonary disease	8.58e-05	0.000584	CcSEcCtD
Omeprazole—Angioedema—Prednisolone—chronic obstructive pulmonary disease	8.48e-05	0.000577	CcSEcCtD
Omeprazole—Vomiting—Salbutamol—chronic obstructive pulmonary disease	8.39e-05	0.000571	CcSEcCtD
Omeprazole—Malaise—Prednisolone—chronic obstructive pulmonary disease	8.37e-05	0.000569	CcSEcCtD
Omeprazole—Vertigo—Prednisolone—chronic obstructive pulmonary disease	8.34e-05	0.000567	CcSEcCtD
Omeprazole—CYP1B1—lung—chronic obstructive pulmonary disease	8.33e-05	0.0302	CbGeAlD
Omeprazole—Rash—Salbutamol—chronic obstructive pulmonary disease	8.32e-05	0.000566	CcSEcCtD
Omeprazole—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	8.32e-05	0.000566	CcSEcCtD
Omeprazole—Nausea—Formoterol—chronic obstructive pulmonary disease	8.31e-05	0.000565	CcSEcCtD
Omeprazole—Nausea—Arformoterol—chronic obstructive pulmonary disease	8.31e-05	0.000565	CcSEcCtD
Omeprazole—Headache—Salbutamol—chronic obstructive pulmonary disease	8.27e-05	0.000563	CcSEcCtD
Omeprazole—CYP1A1—trachea—chronic obstructive pulmonary disease	8.2e-05	0.0298	CbGeAlD
Omeprazole—Nausea—Montelukast—chronic obstructive pulmonary disease	8.14e-05	0.000554	CcSEcCtD
Omeprazole—Hypertension—Prednisolone—chronic obstructive pulmonary disease	8.01e-05	0.000545	CcSEcCtD
Omeprazole—Bradycardia—Prednisone—chronic obstructive pulmonary disease	7.89e-05	0.000537	CcSEcCtD
Omeprazole—Nausea—Salbutamol—chronic obstructive pulmonary disease	7.84e-05	0.000534	CcSEcCtD
Omeprazole—Discomfort—Prednisolone—chronic obstructive pulmonary disease	7.81e-05	0.000531	CcSEcCtD
Omeprazole—Hallucination—Prednisone—chronic obstructive pulmonary disease	7.71e-05	0.000524	CcSEcCtD
Omeprazole—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	7.61e-05	0.000518	CcSEcCtD
Omeprazole—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	7.57e-05	0.000515	CcSEcCtD
Omeprazole—Shock—Prednisolone—chronic obstructive pulmonary disease	7.45e-05	0.000507	CcSEcCtD
Omeprazole—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	7.39e-05	0.000503	CcSEcCtD
Omeprazole—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	7.32e-05	0.000498	CcSEcCtD
Omeprazole—Eye disorder—Prednisone—chronic obstructive pulmonary disease	7.24e-05	0.000493	CcSEcCtD
Omeprazole—Flushing—Prednisone—chronic obstructive pulmonary disease	7.19e-05	0.000489	CcSEcCtD
Omeprazole—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	7e-05	0.000476	CcSEcCtD
Omeprazole—Insomnia—Prednisolone—chronic obstructive pulmonary disease	6.85e-05	0.000466	CcSEcCtD
Omeprazole—Alopecia—Prednisone—chronic obstructive pulmonary disease	6.84e-05	0.000466	CcSEcCtD
Omeprazole—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	6.8e-05	0.000463	CcSEcCtD
Omeprazole—Mental disorder—Prednisone—chronic obstructive pulmonary disease	6.79e-05	0.000462	CcSEcCtD
Omeprazole—Malnutrition—Prednisone—chronic obstructive pulmonary disease	6.74e-05	0.000459	CcSEcCtD
Omeprazole—Pain—Prednisolone—chronic obstructive pulmonary disease	6.48e-05	0.000441	CcSEcCtD
Omeprazole—Vision blurred—Prednisone—chronic obstructive pulmonary disease	6.35e-05	0.000432	CcSEcCtD
Omeprazole—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	6.26e-05	0.000426	CcSEcCtD
Omeprazole—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	6.24e-05	0.000425	CcSEcCtD
Omeprazole—Anaemia—Prednisone—chronic obstructive pulmonary disease	6.23e-05	0.000424	CcSEcCtD
Omeprazole—ABCG2—lung—chronic obstructive pulmonary disease	6.2e-05	0.0225	CbGeAlD
Omeprazole—Agitation—Prednisone—chronic obstructive pulmonary disease	6.2e-05	0.000422	CcSEcCtD
Omeprazole—Angioedema—Prednisone—chronic obstructive pulmonary disease	6.16e-05	0.000419	CcSEcCtD
Omeprazole—Malaise—Prednisone—chronic obstructive pulmonary disease	6.08e-05	0.000414	CcSEcCtD
Omeprazole—Vertigo—Prednisone—chronic obstructive pulmonary disease	6.06e-05	0.000412	CcSEcCtD
Omeprazole—Urticaria—Prednisolone—chronic obstructive pulmonary disease	6.02e-05	0.000409	CcSEcCtD
Omeprazole—CYP1A2—lung—chronic obstructive pulmonary disease	5.97e-05	0.0217	CbGeAlD
Omeprazole—CYP1A1—lung—chronic obstructive pulmonary disease	5.89e-05	0.0214	CbGeAlD
Omeprazole—Hypertension—Prednisone—chronic obstructive pulmonary disease	5.82e-05	0.000396	CcSEcCtD
Omeprazole—ABCB1—respiratory system—chronic obstructive pulmonary disease	5.76e-05	0.0209	CbGeAlD
Omeprazole—Arthralgia—Prednisone—chronic obstructive pulmonary disease	5.74e-05	0.000391	CcSEcCtD
Omeprazole—Myalgia—Prednisone—chronic obstructive pulmonary disease	5.74e-05	0.000391	CcSEcCtD
Omeprazole—Anxiety—Prednisone—chronic obstructive pulmonary disease	5.72e-05	0.000389	CcSEcCtD
Omeprazole—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	5.7e-05	0.000388	CcSEcCtD
Omeprazole—Discomfort—Prednisone—chronic obstructive pulmonary disease	5.67e-05	0.000386	CcSEcCtD
Omeprazole—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	5.58e-05	0.00038	CcSEcCtD
Omeprazole—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	5.5e-05	0.000374	CcSEcCtD
Omeprazole—Infection—Prednisone—chronic obstructive pulmonary disease	5.47e-05	0.000372	CcSEcCtD
Omeprazole—Shock—Prednisone—chronic obstructive pulmonary disease	5.41e-05	0.000368	CcSEcCtD
Omeprazole—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	5.4e-05	0.000367	CcSEcCtD
Omeprazole—Tachycardia—Prednisone—chronic obstructive pulmonary disease	5.37e-05	0.000365	CcSEcCtD
Omeprazole—Skin disorder—Prednisone—chronic obstructive pulmonary disease	5.35e-05	0.000364	CcSEcCtD
Omeprazole—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	5.32e-05	0.000362	CcSEcCtD
Omeprazole—Anorexia—Prednisone—chronic obstructive pulmonary disease	5.25e-05	0.000357	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	5.01e-05	0.000341	CcSEcCtD
Omeprazole—Dizziness—Prednisolone—chronic obstructive pulmonary disease	5.01e-05	0.000341	CcSEcCtD
Omeprazole—Insomnia—Prednisone—chronic obstructive pulmonary disease	4.98e-05	0.000339	CcSEcCtD
Omeprazole—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	4.94e-05	0.000336	CcSEcCtD
Omeprazole—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	4.84e-05	0.00033	CcSEcCtD
Omeprazole—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	4.78e-05	0.000326	CcSEcCtD
Omeprazole—Rash—Prednisolone—chronic obstructive pulmonary disease	4.77e-05	0.000325	CcSEcCtD
Omeprazole—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	4.77e-05	0.000325	CcSEcCtD
Omeprazole—Fatigue—Prednisone—chronic obstructive pulmonary disease	4.74e-05	0.000323	CcSEcCtD
Omeprazole—Headache—Prednisolone—chronic obstructive pulmonary disease	4.74e-05	0.000323	CcSEcCtD
Omeprazole—Constipation—Prednisone—chronic obstructive pulmonary disease	4.71e-05	0.00032	CcSEcCtD
Omeprazole—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	4.53e-05	0.000309	CcSEcCtD
Omeprazole—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	4.5e-05	0.000306	CcSEcCtD
Omeprazole—Nausea—Prednisolone—chronic obstructive pulmonary disease	4.5e-05	0.000306	CcSEcCtD
Omeprazole—Urticaria—Prednisone—chronic obstructive pulmonary disease	4.37e-05	0.000297	CcSEcCtD
Omeprazole—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	4.35e-05	0.000296	CcSEcCtD
Omeprazole—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	4.35e-05	0.000296	CcSEcCtD
Omeprazole—ABCB1—trachea—chronic obstructive pulmonary disease	4.26e-05	0.0155	CbGeAlD
Omeprazole—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	4.05e-05	0.000276	CcSEcCtD
Omeprazole—Asthenia—Prednisone—chronic obstructive pulmonary disease	3.95e-05	0.000269	CcSEcCtD
Omeprazole—Pruritus—Prednisone—chronic obstructive pulmonary disease	3.89e-05	0.000265	CcSEcCtD
Omeprazole—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	3.77e-05	0.000256	CcSEcCtD
Omeprazole—Dizziness—Prednisone—chronic obstructive pulmonary disease	3.64e-05	0.000248	CcSEcCtD
Omeprazole—Vomiting—Prednisone—chronic obstructive pulmonary disease	3.5e-05	0.000238	CcSEcCtD
Omeprazole—Rash—Prednisone—chronic obstructive pulmonary disease	3.47e-05	0.000236	CcSEcCtD
Omeprazole—Dermatitis—Prednisone—chronic obstructive pulmonary disease	3.47e-05	0.000236	CcSEcCtD
Omeprazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	3.46e-05	0.000397	CbGpPWpGaD
Omeprazole—Headache—Prednisone—chronic obstructive pulmonary disease	3.45e-05	0.000235	CcSEcCtD
Omeprazole—CYP2C8—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.43e-05	0.000393	CbGpPWpGaD
Omeprazole—CYP2C8—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.38e-05	0.000387	CbGpPWpGaD
Omeprazole—ABCC3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.31e-05	0.000379	CbGpPWpGaD
Omeprazole—Nausea—Prednisone—chronic obstructive pulmonary disease	3.27e-05	0.000222	CcSEcCtD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	3.25e-05	0.000372	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.23e-05	0.000371	CbGpPWpGaD
Omeprazole—CYP2D6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.23e-05	0.00037	CbGpPWpGaD
Omeprazole—CYP2C19—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.23e-05	0.00037	CbGpPWpGaD
Omeprazole—ABCB1—Allograft Rejection—CXCL8—chronic obstructive pulmonary disease	3.21e-05	0.000368	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	3.21e-05	0.000368	CbGpPWpGaD
Omeprazole—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	3.21e-05	0.000367	CbGpPWpGaD
Omeprazole—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.2e-05	0.000367	CbGpPWpGaD
Omeprazole—CYP2D6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.19e-05	0.000365	CbGpPWpGaD
Omeprazole—CYP2C19—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.18e-05	0.000365	CbGpPWpGaD
Omeprazole—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.16e-05	0.000362	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—GC—chronic obstructive pulmonary disease	3.15e-05	0.00036	CbGpPWpGaD
Omeprazole—ABCB1—Allograft Rejection—IL1B—chronic obstructive pulmonary disease	3.08e-05	0.000353	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	3.08e-05	0.000352	CbGpPWpGaD
Omeprazole—CYP2C19—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.06e-05	0.00035	CbGpPWpGaD
Omeprazole—ABCB1—lung—chronic obstructive pulmonary disease	3.06e-05	0.0111	CbGeAlD
Omeprazole—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	3.05e-05	0.000349	CbGpPWpGaD
Omeprazole—CYP2C19—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.02e-05	0.000346	CbGpPWpGaD
Omeprazole—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	3.01e-05	0.000345	CbGpPWpGaD
Omeprazole—ABCB1—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	3.01e-05	0.000345	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—APIP—chronic obstructive pulmonary disease	3.01e-05	0.000345	CbGpPWpGaD
Omeprazole—CYP2D6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.97e-05	0.00034	CbGpPWpGaD
Omeprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	2.94e-05	0.000337	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.94e-05	0.000337	CbGpPWpGaD
Omeprazole—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.94e-05	0.000337	CbGpPWpGaD
Omeprazole—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.93e-05	0.000335	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.93e-05	0.000335	CbGpPWpGaD
Omeprazole—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.9e-05	0.000332	CbGpPWpGaD
Omeprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	2.89e-05	0.000331	CbGpPWpGaD
Omeprazole—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	2.89e-05	0.000331	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—GC—chronic obstructive pulmonary disease	2.86e-05	0.000328	CbGpPWpGaD
Omeprazole—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.81e-05	0.000322	CbGpPWpGaD
Omeprazole—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.79e-05	0.00032	CbGpPWpGaD
Omeprazole—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.77e-05	0.000318	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	2.77e-05	0.000318	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—APIP—chronic obstructive pulmonary disease	2.76e-05	0.000316	CbGpPWpGaD
Omeprazole—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.75e-05	0.000315	CbGpPWpGaD
Omeprazole—CYP1A2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	2.75e-05	0.000315	CbGpPWpGaD
Omeprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	2.75e-05	0.000315	CbGpPWpGaD
Omeprazole—CYP1A2—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	2.74e-05	0.000313	CbGpPWpGaD
Omeprazole—CYP1A2—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	2.7e-05	0.000309	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.7e-05	0.000309	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—GCLC—chronic obstructive pulmonary disease	2.66e-05	0.000305	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.66e-05	0.000305	CbGpPWpGaD
Omeprazole—ABCB1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	2.61e-05	0.000299	CbGpPWpGaD
Omeprazole—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	2.53e-05	0.00029	CbGpPWpGaD
Omeprazole—CYP1A2—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.51e-05	0.000288	CbGpPWpGaD
Omeprazole—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	2.5e-05	0.000286	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.48e-05	0.000285	CbGpPWpGaD
Omeprazole—CYP1A2—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.48e-05	0.000284	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—APIP—chronic obstructive pulmonary disease	2.46e-05	0.000282	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—CTGF—chronic obstructive pulmonary disease	2.43e-05	0.000278	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	2.4e-05	0.000275	CbGpPWpGaD
Omeprazole—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	2.39e-05	0.000274	CbGpPWpGaD
Omeprazole—CYP1A2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.38e-05	0.000273	CbGpPWpGaD
Omeprazole—CYP1A2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.35e-05	0.000269	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.33e-05	0.000267	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.33e-05	0.000267	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—GCLC—chronic obstructive pulmonary disease	2.31e-05	0.000264	CbGpPWpGaD
Omeprazole—ABCG2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.28e-05	0.000261	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.27e-05	0.00026	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	2.26e-05	0.000259	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	2.24e-05	0.000257	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—GCLC—chronic obstructive pulmonary disease	2.24e-05	0.000257	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.24e-05	0.000257	CbGpPWpGaD
Omeprazole—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	2.23e-05	0.000256	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.14e-05	0.000246	CbGpPWpGaD
Omeprazole—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	2.11e-05	0.000242	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—CTGF—chronic obstructive pulmonary disease	2.1e-05	0.000241	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.09e-05	0.00024	CbGpPWpGaD
Omeprazole—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	2.08e-05	0.000239	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—CTGF—chronic obstructive pulmonary disease	2.05e-05	0.000234	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.99e-05	0.000228	CbGpPWpGaD
Omeprazole—ABCC3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.99e-05	0.000228	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.98e-05	0.000226	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.97e-05	0.000225	CbGpPWpGaD
Omeprazole—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	1.94e-05	0.000222	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—GC—chronic obstructive pulmonary disease	1.94e-05	0.000222	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.94e-05	0.000222	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	1.92e-05	0.00022	CbGpPWpGaD
Omeprazole—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	1.91e-05	0.000219	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.89e-05	0.000216	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.87e-05	0.000214	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.84e-05	0.000211	CbGpPWpGaD
Omeprazole—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	1.84e-05	0.000211	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.83e-05	0.000209	CbGpPWpGaD
Omeprazole—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	1.81e-05	0.000208	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.81e-05	0.000207	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.8e-05	0.000206	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—GC—chronic obstructive pulmonary disease	1.78e-05	0.000204	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.75e-05	0.000201	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.72e-05	0.000197	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.72e-05	0.000197	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.7e-05	0.000195	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.65e-05	0.000189	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.63e-05	0.000187	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.63e-05	0.000186	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.62e-05	0.000185	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.62e-05	0.000185	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.6e-05	0.000183	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.59e-05	0.000183	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.59e-05	0.000182	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	1.59e-05	0.000182	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.58e-05	0.000182	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.57e-05	0.00018	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.56e-05	0.000179	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.55e-05	0.000178	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.55e-05	0.000178	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	1.55e-05	0.000177	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—GCLC—chronic obstructive pulmonary disease	1.55e-05	0.000177	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.5e-05	0.000172	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.49e-05	0.00017	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.49e-05	0.00017	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	1.48e-05	0.00017	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.47e-05	0.000169	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.47e-05	0.000169	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	1.46e-05	0.000167	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	1.45e-05	0.000166	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.44e-05	0.000166	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.44e-05	0.000165	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.43e-05	0.000164	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—CTGF—chronic obstructive pulmonary disease	1.41e-05	0.000162	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.41e-05	0.000161	CbGpPWpGaD
Omeprazole—ABCG2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.37e-05	0.000157	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.37e-05	0.000157	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.37e-05	0.000157	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.36e-05	0.000155	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.34e-05	0.000154	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.32e-05	0.000151	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.3e-05	0.000149	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	1.29e-05	0.000147	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.27e-05	0.000146	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	1.24e-05	0.000142	CbGpPWpGaD
Omeprazole—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	1.23e-05	0.000141	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.19e-05	0.000137	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	1.18e-05	0.000135	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.18e-05	0.000135	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.17e-05	0.000135	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	1.16e-05	0.000133	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.15e-05	0.000132	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—ALB—chronic obstructive pulmonary disease	1.11e-05	0.000127	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	1.1e-05	0.000126	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.1e-05	0.000125	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.08e-05	0.000124	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.07e-05	0.000123	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.07e-05	0.000122	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.06e-05	0.000121	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.06e-05	0.000121	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.05e-05	0.00012	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.04e-05	0.000119	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.96e-06	0.000114	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	9.8e-06	0.000112	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	9.76e-06	0.000112	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	9.72e-06	0.000111	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.71e-06	0.000111	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—GCLC—chronic obstructive pulmonary disease	9.59e-06	0.00011	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—ALB—chronic obstructive pulmonary disease	9.57e-06	0.00011	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—CTGF—chronic obstructive pulmonary disease	9.55e-06	0.000109	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	9.54e-06	0.000109	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.44e-06	0.000108	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—ALB—chronic obstructive pulmonary disease	9.31e-06	0.000107	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—NOS3—chronic obstructive pulmonary disease	9.16e-06	0.000105	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	9.15e-06	0.000105	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	8.95e-06	0.000102	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—NOS3—chronic obstructive pulmonary disease	8.91e-06	0.000102	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	8.87e-06	0.000102	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.8e-06	0.000101	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—CTGF—chronic obstructive pulmonary disease	8.76e-06	0.0001	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.66e-06	9.92e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	8.56e-06	9.81e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.46e-06	9.69e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	8.36e-06	9.58e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.07e-06	9.24e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	7.98e-06	9.15e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.97e-06	9.13e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.9e-06	9.05e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	7.88e-06	9.02e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	7.81e-06	8.95e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	7.81e-06	8.95e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	7.63e-06	8.74e-05	CbGpPWpGaD
Omeprazole—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	7.41e-06	8.49e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.34e-06	8.41e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	7.28e-06	8.34e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.24e-06	8.29e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.2e-06	8.25e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	7.19e-06	8.23e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	7.13e-06	8.16e-05	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—ALB—chronic obstructive pulmonary disease	7.06e-06	8.08e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.03e-06	8.05e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.75e-06	7.73e-05	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—NOS3—chronic obstructive pulmonary disease	6.75e-06	7.73e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.74e-06	7.73e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.73e-06	7.71e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	6.67e-06	7.64e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.64e-06	7.6e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.62e-06	7.59e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.57e-06	7.52e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—ALB—chronic obstructive pulmonary disease	6.42e-06	7.35e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	6.22e-06	7.13e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.18e-06	7.08e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—NOS3—chronic obstructive pulmonary disease	6.14e-06	7.03e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	6.09e-06	6.98e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.01e-06	6.88e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.92e-06	6.78e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.86e-06	6.71e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.86e-06	6.71e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.78e-06	6.62e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.52e-06	6.33e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.52e-06	6.32e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.48e-06	6.27e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.45e-06	6.24e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.4e-06	6.19e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.39e-06	6.17e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.23e-06	5.99e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.21e-06	5.97e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	5.15e-06	5.9e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.11e-06	5.85e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.08e-06	5.81e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.03e-06	5.76e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.81e-06	5.51e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.77e-06	5.46e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	4.7e-06	5.38e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.68e-06	5.36e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.61e-06	5.29e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—ALB—chronic obstructive pulmonary disease	4.35e-06	4.98e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.33e-06	4.96e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.3e-06	4.93e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—NOS3—chronic obstructive pulmonary disease	4.16e-06	4.76e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.08e-06	4.67e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—ALB—chronic obstructive pulmonary disease	3.98e-06	4.56e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—NOS3—chronic obstructive pulmonary disease	3.81e-06	4.37e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.61e-06	4.14e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.56e-06	4.08e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	3.56e-06	4.07e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	3.47e-06	3.98e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	3.4e-06	3.9e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	3.32e-06	3.8e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.32e-06	3.8e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	3.27e-06	3.75e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	3.24e-06	3.71e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.15e-06	3.6e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	3.13e-06	3.58e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	3.1e-06	3.55e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	2.77e-06	3.17e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	2.65e-06	3.04e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	2.14e-06	2.45e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	2.05e-06	2.34e-05	CbGpPWpGaD
